The phytocannabinoids of Cannabis sativa L. have, since ancient times, been proposed as a
pharmacological alternative for treating various central nervous system (CNS) disorders …

Although the medicinal properties of Cannabis species have been known for centuries, the
interest on its main active secondary metabolites as therapeutic alternatives for several …

The purpose of this study was to investigate whether the anxiolytic effect of cannabidiol
(CBD) in humans follows the same pattern of an inverted U-shaped dose-effect curve …

Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating
conditions linked to oxidative stress and neurodegeneration. When available, the …

Simple Summary Cannabidiol (CBD) is one of the main constituents of the plant Cannabis
sativa. Surveys suggest that medicinal cannabis is popular amongst people diagnosed with …

Medicinal use of Cannabis sativa L. has an extensive history and it was essential in the
discovery of phytocannabinoids, including the Cannabis major psychoactive compound—Δ9 …

Ethnopharmacological relevance The plants are from the genus Rauvolfia Plum. ex
L.(Apocynaceae), which is represented by 74 species with many synonyms, and distributed …

The literature provides scientific evidence for the beneficial effects of cannabidiol (CBD), and
these effects extend beyond epilepsy treatment (eg, Lennox–Gastaut and Dravet …

Background: Cannabidiol (CBD) is among the major secondary metabolites of Cannabis
devoid of the delta-9-tetra-hydrocannabinol psychoactive effects. It is a resorcinol-based …

Parkinson's disease (PD) is a chronic neurodegenerative disorder characterized by motor
symptoms such as bradykinesia, rest tremor, postural disturbances, and rigidity. PD is also …